Literature DB >> 2900709

Dynamic heterogeneity: metastatic variants to liver are generated spontaneously in mouse embryonal carcinoma cells.

J F Harris1, M W Best.   

Abstract

Mouse embryonal carcinoma (EC) cells derived from F9 cells form predominantly liver tumors following the intravenous injection (i.e. experimental metastasis assay) of EC cells into syngeneic 129/J male mice. In this study, EC cells (OTF9) expressing stage-specific embryonic antigen-1 (SSEA-1) are compared with cells (SOTF9) lacking SSEA-1 antigen in the experimental liver metastasis assay. When parallel clones of EC cells were grown to a measured cell number and tested in the experimental metastasis assay, it was observed that the frequency of experimental liver metastases increases with the population size. When the clonal population size is less than the critical number of cells (approximately 2 x 10(5) cells), the frequency of liver tumors is reduced relative to that of the parent EC population. The metastatic ability of clones derived from individual liver metastases did not differ from that of the parental cells. An analysis of the recessive biochemical and immunochemical markers of parental cells and of independent liver metastases suggests that somatic hybridization to host cells by the EC cells is not involved. These results are consistent with predictions from our dynamic heterogeneity model that was formulated by examining the experimental lung metastasis of KHT fibrosarcoma and B16 melanoma cells. Mathematical analysis of the results indicates that the effective rate of generation of the liver metastasizing variant cells is (7 +/- 3) x 10(-6) per cell per generation for both OTF9 and SOTF9 cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900709     DOI: 10.1007/bf01784376

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  35 in total

1.  In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity.

Authors:  J H Xiang; A K Kimura
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

2.  The distribution of the numbers of mutants in bacterial populations.

Authors:  D E LEA; C A COULSON
Journal:  J Genet       Date:  1949-12       Impact factor: 1.166

3.  A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses.

Authors:  W C Russell; C Newman; D H Williamson
Journal:  Nature       Date:  1975-02-06       Impact factor: 49.962

4.  Ovarian localization by embryonal teratocarcinoma cells derived from female germ gells.

Authors:  B Kahan
Journal:  Somatic Cell Genet       Date:  1979-11

5.  Dynamic heterogeneity: isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype.

Authors:  S D Young; R P Hill
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

6.  Alkaline phosphatase activity in mouse teratoma.

Authors:  E G Berstine; M L Hooper; S Grandchamp; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.

Authors:  C Cillo; J E Dick; V Ling; R P Hill
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

Review 8.  'Seed and soil' revisited: mechanisms of site-specific metastasis.

Authors:  I R Hart
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  Male murine embryonal carcinoma cell line selectively metastatic to the ovaries and adrenals.

Authors:  N Fox; L DeSouza; D Simon; I Damjanov
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1983

10.  Isolation and characterization of an embryonal carcinoma cell line lacking SSEA-1 antigen.

Authors:  M J Rosenstraus
Journal:  Dev Biol       Date:  1983-10       Impact factor: 3.582

View more
  5 in total

1.  Modulation of clonal progression in B16F1 melanoma cells.

Authors:  J F Harris; A F Chambers; A S Tam
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.

Authors:  B M Korycka; R P Hill
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

3.  Sulfated glycoconjugate determinants recognized by monoclonal antibody, SG-1, correlate with the experimental metastatic ability of KHT fibrosarcoma cells.

Authors:  J F Harris; D W Beaton
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

Review 4.  Molecular pathology underlying the robustness of cancer stem cells.

Authors:  Go J Yoshida; Hideyuki Saya
Journal:  Regen Ther       Date:  2021-03-25       Impact factor: 3.419

Review 5.  Therapeutic strategies targeting cancer stem cells.

Authors:  Go J Yoshida; Hideyuki Saya
Journal:  Cancer Sci       Date:  2015-10-21       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.